The transcription repressors bach2 and bach1 promote b cell development by repressing the myeloid program
The transcription repressors bach2 and bach1 promote b cell development by repressing the myeloid program"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Mature lymphoid cells express the transcription repressor Bach2, which imposes regulation on humoral and cellular immunity. Here we found critical roles for Bach2 in the development
of cells of the B lineage, commencing from the common lymphoid progenitor (CLP) stage, with Bach1 as an auxiliary. Overexpression of Bach2 in pre-pro-B cells deficient in the transcription
factor EBF1 and single-cell analysis of CLPs revealed that Bach2 and Bach1 repressed the expression of genes important for myeloid cells ('myeloid genes'). Bach2 and Bach1 bound to
presumptive regulatory regions of the myeloid genes. Bach2hi CLPs showed resistance to myeloid differentiation even when cultured under myeloid conditions. Our results suggest that Bach2
functions with Bach1 and EBF1 to promote B cell development by repressing myeloid genes in CLPs. Access through your institution Buy or subscribe This is a preview of subscription content,
access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn
more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS
OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS AN ERG-DRIVEN TRANSCRIPTIONAL PROGRAM CONTROLS B
CELL LYMPHOPOIESIS Article Open access 15 June 2020 THE TRANSCRIPTION FACTOR HHEX COOPERATES WITH THE COREPRESSOR TLE3 TO PROMOTE MEMORY B CELL DEVELOPMENT Article 29 June 2020
ANTIBODY-SECRETING CELL DESTINY EMERGES DURING THE INITIAL STAGES OF B-CELL ACTIVATION Article Open access 10 August 2020 ACCESSION CODES PRIMARY ACCESSIONS GENE EXPRESSION OMNIBUS *
GSE61409 REFERENCES * Adolfsson, J. et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment.
_Cell_ 121, 295–306 (2005). CAS PubMed Google Scholar * Mansson, R. et al. Single-cell analysis of the common lymphoid progenitor compartment reveals functional and molecular
heterogeneity. _Blood_ 115, 2601–2609 (2010). CAS PubMed Google Scholar * Ishikawa, F. et al. The developmental program of human dendritic cells is operated independently of conventional
myeloid and lymphoid pathways. _Blood_ 110, 3591–3660 (2007). CAS PubMed PubMed Central Google Scholar * Huang, S., Guo, Y.P., May, G. & Enver, T. Bifurcation dynamics in
lineage-commitment in bipotent progenitor cells. _Dev. Biol._ 305, 695–713 (2007). CAS PubMed Google Scholar * Månsson, R. et al. Molecular evidence for hierarchical transcriptional
lineage priming in fetal and adult stem cells and multipotent progenitors. _Immunity_ 26, 407–419 (2007). PubMed Google Scholar * Pongubala, J.M. et al. Transcription factor EBF restricts
alternative lineage options and promotes B cell fate commitment independently of Pax5. _Nat. Immunol._ 9, 203–215 (2008). CAS PubMed Google Scholar * Kikuchi, K., Lai, A.Y., Hsu, C.L.
& Kondo, M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. _J. Exp. Med._ 201, 1197–1203 (2005). CAS PubMed PubMed
Central Google Scholar * Roessler, S. et al. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. _Mol. Cell. Biol._ 27, 579–594 (2007). CAS PubMed
Google Scholar * Zandi, S. et al. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors. _J. Immunol._ 181, 3364–3372
(2008). CAS PubMed Google Scholar * Lin,, Y.C. et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. _Nat. Immunol._ 11, 635–643
(2010). CAS Google Scholar * Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. _Nature_ 401, 556–562
(1999). CAS PubMed Google Scholar * Zandi, S. et al. Single-cell analysis of early B-lymphocyte development suggests independent regulation of lineage specification and commitment _in
vivo_. _Proc. Natl. Acad. Sci. USA_ 109, 15871–15876 (2012). CAS PubMed PubMed Central Google Scholar * Xie, H., Ye, M., Feng, R. & Graf, T. Stepwise reprogramming of B cells into
macrophages. _Cell_ 117, 663–676 (2004). CAS PubMed Google Scholar * Di Tullio, A. et al. CCAAT/enhancer binding protein α (C/EBPα)-induced transdifferentiation of pre-B cells into
macrophages involves no overt retrodifferentiation. _Proc. Natl. Acad. Sci. USA_ 108, 17016–17021 (2011). CAS PubMed PubMed Central Google Scholar * Oyake, T. et al. Bach proteins belong
to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. _Mol. Cell. Biol._ 16, 6083–6095 (1996). CAS
PubMed PubMed Central Google Scholar * Muto, A. et al. The transcriptional programme of antibody class switching involves the repressor Bach2. _Nature_ 429, 566–571 (2004). CAS PubMed
Google Scholar * Muto, A. et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. _EMBO J._ 29, 4048–4061 (2010). CAS PubMed PubMed Central
Google Scholar * Swaminathan, S. et al. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. _Nat. Med._ 19, 1014–1022 (2013). CAS
PubMed PubMed Central Google Scholar * Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. _Nature_ 498, 506–510 (2013). CAS PubMed
PubMed Central Google Scholar * Tsukumo, S. et al. Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. _Proc. Natl. Acad. Sci. USA_ 110, 10735–10740
(2013). CAS PubMed PubMed Central Google Scholar * Nakamura, A. et al. Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function.
_J. Exp. Med._ 210, 2191–2204 (2013). CAS PubMed PubMed Central Google Scholar * McManus, S. et al. The transcription factor Pax5 regulates its target genes by recruiting
chromatin-modifying proteins in committed B cells. _EMBO J._ 30, 2388–2404 (2011). CAS PubMed PubMed Central Google Scholar * Nakano, T., Kodama, H. & Honjo, T. Generation of
lymphohematopoietic cells from embryonic stem cells in culture. _Science_ 265, 1098–1101 (1994). CAS PubMed Google Scholar * Williams, D.E., Namen, A.E., Mochizuki, D.Y. & Overell,
R.W. Clonal growth of murine pre-B colony-forming cells and their targeted infection by a retroviral vector: dependence on interleukin-7. _Blood_ 75, 1132–1138 (1990). CAS PubMed Google
Scholar * Dias, S., Silva, H. Jr., Cumano, A. & Vieira, P. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. _J. Exp. Med._ 201, 971–979
(2005). CAS PubMed PubMed Central Google Scholar * Mansson, R. et al. B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. _Blood_ 112,
1048–1055 (2008). CAS PubMed Google Scholar * Ikawa, T. et al. An essential developmental checkpoint for production of the T cell lineage. _Science_ 329, 93–96 (2010). CAS PubMed Google
Scholar * Matsumoto, A. et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. _Blood_ 89, 3148–3154 (1997). CAS PubMed Google
Scholar * Inlay, M.A. et al. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. _Genes Dev._ 23, 2376–2381 (2009).
CAS PubMed PubMed Central Google Scholar * Dias, S. et al. E2A proteins promote development of lymphoid-primed multipotent progenitors. _Immunity_ 29, 217–227 (2008). CAS PubMed PubMed
Central Google Scholar * Sun, J. et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. _EMBO J._ 21, 5216–5224 (2002). CAS PubMed PubMed Central Google
Scholar * Smith, E.M. et al. Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development. _Blood_ 106, 1995–2001 (2005). CAS PubMed
Google Scholar * DeKoter, R.P. & Singh, H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. _Science_ 288, 1439–1441 (2000). CAS PubMed Google
Scholar * Wada, H. et al. Adult T-cell progenitors retain myeloid potential. _Nature_ 452, 768–772 (2008). CAS PubMed Google Scholar * Li, L., Leid, M. & Rothenberg, E.V. An early T
cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. _Science_ 329, 89–93 (2010). CAS PubMed PubMed Central Google Scholar * Kohyama, M. et al. Role for Spi-C
in the development of red pulp macrophages and splenic iron homeostasis. _Nature_ 457, 318–321 (2009). CAS PubMed Google Scholar * Zhu, X. et al. Transgenic expression of Spi-C impairs
B-cell development and function by affecting genes associated with BCR signaling. _Eur. J. Immunol._ 38, 2587–2599 (2008). CAS PubMed PubMed Central Google Scholar * Blake, W.J., M K,
A., Cantor, C.R. & Collins, J.J. Noise in eukaryotic gene expression. _Nature_ 422, 633–637 (2003). CAS PubMed Google Scholar * Munsky, B., Neuert, G. & van, O.A. Using gene
expression noise to understand gene regulation. _Science_ 336, 183–187 (2012). CAS PubMed PubMed Central Google Scholar * Watanabe-Matsui, M. et al. Heme regulates B cell
differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. _Blood_ 117, 5438–5448 (2011). CAS PubMed Google Scholar * Igarashi, K. &
Watanabe-Matsui, M. Wearing red for signaling: the heme-bach axis in heme metabolism, oxidative stress response and iron immunology. _Tohoku J. Exp. Med._ 232, 229–253 (2014). CAS PubMed
Google Scholar * Guo, G. et al. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. _Dev. Cell_ 18, 675–685 (2010). CAS PubMed
Google Scholar * Muto, A. et al. Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies. _J. Biol.
Chem._ 277, 20724–20733 (2002). CAS PubMed Google Scholar * Mandal, M. et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2.
_Nat. Immunol._ 12, 1212–1220 (2011). CAS PubMed PubMed Central Google Scholar * Ochiai, K. et al. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR
signaling and differentiation. _Nat. Immunol._ 13, 300–307 (2012). CAS PubMed PubMed Central Google Scholar * Igarashi, K., Itoh, K., Hayashi, N., Nishizawa, M. & Yamamoto, M
Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation. _Proc. Natl. Acad. Sci. USA_ 92, 7445–7449 (1995). CAS PubMed PubMed
Central Google Scholar Download references ACKNOWLEDGEMENTS We thank H. Singh (Cincinnati Children's Hospital Medical Center) for discussions, the _Ebf1_ retroviral construct and
_Ebf1_−/− cells; M.R. Clark (University of Chicago) for the retroviral construct encoding constitutively active STAT5b; K. Takatsu (Toyama University) for OP9 stroma cells; T. Iino, A.
Akashi, A. Brydun and M. Matsumoto for advice on DNA microarray analysis; A. Brydun for the generation of antibody to Bach1; R. Yamashita for advice on the analysis of modules from the
Immunological Genome Project; H. Kawamoto and members of the Igarashi laboratory for discussions; A. Arakawa for help in the generation of Bach2 reporter mice; K. Watanabe for help with
experiments; M. Satake for discussions about repressors; and the Biomedical Research Core of Tohoku University Graduate School of Medicine for their technical support. Supported by
Grants-in-Aid from the Japan Society for the Promotion of Science (09J07369 to A.I.-N.; 21229007 to T.K.; 00250738, 21249014 and 00250738 to K.I.), the Network Medicine Global-COE Program of
the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Uehara Foundation, the Takeda Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science and
Astellas Foundation for Research on Metabolic Disorders, and the Japan Society for the Promotion of Science and the Tohoku University Institute for International Advanced Research and
Education (A.I.-N.). AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan Ari Itoh-Nakadai, Reina Hikota,
Akihiko Muto, Miki Watanabe-Matsui, Yuki Sato, Masahiro Kobayashi, Atsushi Nakamura, Yuichi Miura, Kyoko Ochiai & Kazuhiko Igarashi * CREST, Japan Science and Technology Agency, Sendai,
Japan Ari Itoh-Nakadai, Akihiko Muto, Kyoko Ochiai & Kazuhiko Igarashi * RIKEN Center for Integrative Medical Sciences, Yokohama, Japan Kohei Kometani & Tomohiro Kurosaki *
Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan Yoko Yano, Satoshi
Tashiro & Jiying Sun * Laboratory for Immune Regeneration RIKEN Center for Integrative Medical Sciences, Yokohama, Japan Tomokatsu Ikawa * Center for Regulatory Epigenome and Diseases,
Tohoku University Graduate School of Medicine, Sendai, Japan Kyoko Ochiai & Kazuhiko Igarashi * WPI Immunology Frontier Research Center, Osaka University, Suita, Japan Tomohiro Kurosaki
Authors * Ari Itoh-Nakadai View author publications You can also search for this author inPubMed Google Scholar * Reina Hikota View author publications You can also search for this author
inPubMed Google Scholar * Akihiko Muto View author publications You can also search for this author inPubMed Google Scholar * Kohei Kometani View author publications You can also search for
this author inPubMed Google Scholar * Miki Watanabe-Matsui View author publications You can also search for this author inPubMed Google Scholar * Yuki Sato View author publications You can
also search for this author inPubMed Google Scholar * Masahiro Kobayashi View author publications You can also search for this author inPubMed Google Scholar * Atsushi Nakamura View author
publications You can also search for this author inPubMed Google Scholar * Yuichi Miura View author publications You can also search for this author inPubMed Google Scholar * Yoko Yano View
author publications You can also search for this author inPubMed Google Scholar * Satoshi Tashiro View author publications You can also search for this author inPubMed Google Scholar *
Jiying Sun View author publications You can also search for this author inPubMed Google Scholar * Tomokatsu Ikawa View author publications You can also search for this author inPubMed Google
Scholar * Kyoko Ochiai View author publications You can also search for this author inPubMed Google Scholar * Tomohiro Kurosaki View author publications You can also search for this author
inPubMed Google Scholar * Kazuhiko Igarashi View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS A.I.-N. performed all experiments with the help
of R.H., A.M., M.W.-M., Y.S., M.K., A.N., Y.M., Y.Y., S.T., J.S., T.I. and K.O.; R.H. performed multiplex-single-cell PCR analysis; M.W.-M. performed electrophoretic mobility-shift assays;
K.K. and T.K. generated Bach2 reporter mice; A.I.-N. designed the study and wrote the manuscript; K.I. supervised the project and wrote the manuscript; and all authors discussed the results
and their implications and commented on the manuscript. CORRESPONDING AUTHOR Correspondence to Kazuhiko Igarashi. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing
financial interests. INTEGRATED SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE 1 CD19+ PRO-B CELLS ARE LESS ABUNDANT IN _BACH1_–/–_BACH2_–/– MICE. The data were obtained from mice distinct
from those analyzed in Fig. 1b using same analyzer and antibodies of colors. A. Flow cytometry analysis of CD19+ pro-B cells. Bone marrow cells of WT and DD mice were analysed by FACSAriaII
for surface expression of PerCP-cy5.5-CD19+ (ID3;BD), FITC-CD43+, (S7;BD) and APC-B220+ (RA3-6B2;TONBO). B. Absolute cell numbers of pro-B cells and CD19+ cells in pro-B cells in bone marrow
of WT (n = 3) and DD mice (n = 4). The data were analyzed using unpaired Student’s _t_-test. The results are presented as the means ± S.E.M. from three individual experiments. SUPPLEMENTARY
FIGURE 2 NORMAL EARLY T CELL DEVELOPMENT IN THE THYMUS OF _BACH1_–/–_BACH2_–/– MICE. A. Flow cytometry analysis of T cells in the thymus. ETP from WT, _Bach1_-/-, _Bach2_-/-, and DD mice
were analysed for surface expression of Lin-, CD25- and c-Kit+. B. Absolute cell numbers of indicated cell populations in the thymus from WT (white columns, n=4), _Bach1_-/- (line columns, n
= 2), _Bach2_-/-(gray columns, n = 2), and DD (black columns, n=4) mice. Total T cells (CD4+CD8–, CD4–CD8+), ETP (Lin–CD4–CD8–c-Kit+CD25–), DN2 (Lin–CD4–CD8–c-Kit+CD25+) and DN3
(Lin–CD4–CD8–c-Kit–CD25–) in the thymus. The data were analyzed using unpaired Student’s _t_-test. SUPPLEMENTARY FIGURE 3 METHODS FOR THE ANALYSIS OF CLPS AND INTRACELLULAR PHOSPHORYLATED
STAT5. A. Flow cytometry analysis of CLPs. WT bone marrow cells were analysed for surface expression of Lin–, PI–, IL7Ra+, c-kitmid, Flt3+ and Sca-1mid. The staining reagents are described
in online materials and methods. B. Surface marker staining of Lin– cells sorted by MACS. C. The levels of phosphorylated STAT5 (pSTAT5) of CLPs obtained from WT (dotted line) and DD (solid
line) mice. The shaded histogram represents the results obtained with an isotype control (gray). High phosphorylation areas (not detected with the isotype control) were gated. SUPPLEMENTARY
FIGURE 4 FLOW CYTOMETRY OF GFP– CELLS AMONG INFECTED _EBF1_–/– CELLS. FACS analysis of GFP–negative, uninfected cells in _Ebf1_-/- cells treated with retroviruses carrying indicated genes.
Contour plots of GFP-negative cells in the experiment depicted in Fig. 3e are shown. Frequency values are mean of three experiments ± s.e.m. The data were analyzed using unpaired two tailed
Student’s _t_-test. There was no statistical significance among groups. SUPPLEMENTARY FIGURE 5 SCHEMATIC DRAWINGS OF THE PREPARATION OF MICROARRAY SAMPLES IN FIGURE 4. SUPPLEMENTARY FIGURE 6
THE SEARCH FOR BINDING LOCUS OF BACH FACTORS. A. Schematic representation of the MARE-like sequences of Cebpb, Ahr, Ly96, Spic, Bach1, Cish and Spi1.The arrows denote MARE-like sequences.
B. Specificity of anti-Bach1 monoclonal antibody. Monoclonal antibody N9648 against mouse Bach1 was generated by immunizing mice with recombinant mouse Bach1 fragment (amino acid residues
318-392) and by establishing hybridoma clones from the spleens. The specificity of the antibody was confirmed by western blotting of extracts prepared from wild-type and _Bach1_-deficient
embryonic fibroblasts. C. EMSA showing binding of Bach1 to the putative MAREs. EMSA was carried out using total 100 ng proteins (MBP-Bach1 or MBP-Mafk) with oligonucleotide probe which
contained the MARE-like sequences of Ahr or Cebpb. Arrows indicate bindings of Bach1 (homodimer), Bach1-MafK (heterodimer) and MafK (homodimer). WT and Mut indicate competitor DNAs with
wild-type and mutated sequences, respectively. SUPPLEMENTARY FIGURE 7 CLUSTERING ANALYSIS OF SINGLE-CELL ANALYSIS OF WILD-TYPE AND _BACH1_–/–_BACH2_–/– CLPS. Gene expression of a single CLP
in WT and DD was analysed by 48.48 dynamic arrays on a BioMark system using 218-219 cells for each genotype. Clustering analysis of total CLPs (A) and EBF1+ CLPs (B) population in WT and DD
CLPs were carried out using myeloid-related genes. SUPPLEMENTARY FIGURE 8 GENERATION OF BACH2-TD RFP REPORTER MICE. A. Generation of Bach2-td RFP reporter mice. Schematic diagram of Bach2-td
RFP reporter mice. Arrows indicate primer position for PCR. The length of PCR product for wild type (wt) and knock in allele (KI) is 402bp and 248bp, respectively. To generate Bach2-tandem
red fluorescent protein (tdRFP) targeted mice, homology region of Bach2, 6kb long arm (LA) and 2.5kb short arm (SA), were subcloned into a vector containing a diphtheria toxin A (DTA) gene.
One tdRFP gene conjugated with neomycin resistant cassette flanked with two FRT sequences was inserted in Bach2 start codon site. The targeting vector was electroporated into C57BL/6-derived
Bruce4 embryonic stem cells. After the selection with G418, correctly targeted clones were identified by PCR. The targeted ES clones were injected into blastocysts from BALB/c mice. The
obtained chimeric mice were crossed with C57BL/6 mice to obtain germline transmitted animals. To remove the neomycine resistant casette, CAG-Flp transgenic mice were further crossed. B.
Sorting of CLPs depending on expression of Bach2 RFP. The bottom panels show re-analysis of sorted Bach2hi (left) and Bach2lo (right) CLPs. C. Regulatory interactions of _Bach1_, _Bach2_,
and _Ebf1_ with other genes. The network was assembled using BioTapestry (http://www.biotapestry.org/). Activating and repressive interactions are indicated with arrowheads and stop lines,
respectively. SUPPLEMENTARY INFORMATION SUPPLEMENTARY TEXT AND FIGURES Supplementary Figures 1–8 and Supplementary Tables 1–12 (PDF 10558 kb) SUPPLEMENTARY DATASET Single cell PCR Ct value
(XLSX 1144 kb) SOURCE DATA SOURCE DATA TO FIG. 1 SOURCE DATA TO FIG. 2 SOURCE DATA TO FIG. 3 SOURCE DATA TO FIG. 4 SOURCE DATA TO FIG. 5 RIGHTS AND PERMISSIONS Reprints and permissions ABOUT
THIS ARTICLE CITE THIS ARTICLE Itoh-Nakadai, A., Hikota, R., Muto, A. _et al._ The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.
_Nat Immunol_ 15, 1171–1180 (2014). https://doi.org/10.1038/ni.3024 Download citation * Received: 15 August 2014 * Accepted: 01 October 2014 * Published: 26 October 2014 * Issue Date:
December 2014 * DOI: https://doi.org/10.1038/ni.3024 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link
is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
Trending News
Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patientsABSTRACT BACKGROUND Expensive cancer treatment calls for alternative ways such as drug repurposing to develop effective ...
Wardrobe do-overs for midwinter fashion bluesMemorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
Multimodal joint deconvolution and integrative signature selection in proteomicsABSTRACT Deconvolution is an efficient approach for detecting cell-type-specific (cs) transcriptomic signals without cel...
English is language of europe a report has foundThe study revealed that 97 per cent of children across the continent now learn English – and that is according to the Eu...
Sinema took wall street money while killing tax on investorsWASHINGTON — Sen. Kyrsten Sinema, the Arizona Democrat who single-handedly thwarted her party’s longtime goal of raising...
Latests News
The transcription repressors bach2 and bach1 promote b cell development by repressing the myeloid programABSTRACT Mature lymphoid cells express the transcription repressor Bach2, which imposes regulation on humoral and cellul...
shilovichПонравилось выступление, особенно по сравнению с прошлым годами, не прогадали они не разу! Шакира , конечно, попой шикар...
Older americans are stuck in low-paying, unstable jobsMemorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4 G...
FMG not keen on BC's ore | The West AustralianThe West Australian UPDATE 1.55PM: Fortescue Metals Group has declined to buy low-grade iron ore from its Nullagine join...
2017: key changes that will affect youEVENTS AND CULTURE FOR THE first time in 25 years the Tour de France will cover all five mountain ranges in France. Afte...